tyrosine kinase inhibitor - Globe Thesis

Keyword [tyrosine kinase inhibitor] Result: 181 - 200 \| Page: 10 of 10
181.	Axitinib,A Multi-target Tyrosine Kinase Inhibitor,Induces Growth Arrest In Human Hepatocellular Carcinoma SNU-423 Cells
182.	Study On The Synthesis And Anti-tumor Activities Of 6-Aryl Alkoxy Pteridines Derivates
183.	Clinical Efficacy Of Third-line Tyrosine Kinase Inhibitors In Advanced Gastrointestinal Stromal Tumors After Failure Of Imatinib And Sunitinib: A Meta-analysis Of Recent Clinical Trials
184.	Clinical Study On The Influential Factors Of Aquired Resistance To EGFR-TKI And The Treatment Strategy After Drug Resistance In Non-small Cell Lung Cancer
185.	The Case Analysis Of Epidermal Growth Factor Receptor-targeted Therapies Combined With Chemoradiotherapy In Esophageal Squamous Cell Carcinoma And Literature Review
186.	Effect Of Tyrosine Kinase Inhibitor On Autophagy Of Chronic Myeloid Leukemia And Its Mechanism
187.	Dynamic Monitoring Of Lymphocyte Subpopulation During The EGFR-TKI Therapy For Predicting The Efficacy And Resistance Of EGFR-TKI In EGFR Mutated Lung Cancer Patients
188.	The Efficacy Of Tyrosine Kinase Inhibitor In Patients With Different Bcr/abl Transcript Types Of Chronic Myeloid Leukemia:A Meta-analysis
189.	The Epidemiological Investigation And Clinical Observation Of XXXX01 For The Treatment Of The Rash Caused By EGFR-TKIs In NSCLC
190.	N-substituted Benzylidene Pyrrolidine Diketone Compounds Screeing Activity And Mechanism Of Anti-angiogensis Study
191.	Ibrutinib,a Bruton's Tyrosine Kinase Inhibitor,exhibits Anti-Tumoral Activity And Induces Autophagy In Glioblastoma
192.	Intracranial Control And Survival Outcome Of Whole Brain Radiotherapy(WBRT) Alone Versus WBRT Plus Radiotherapy Boost For Non-small Cell Lung Cancer With Brain Metastases
193.	Study Of A Novel EGFR Tyrosine Kinase Inhibitor In The Treatment Of Prostate Cancer
194.	Effect And Quality Of Life Of 77 Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitor Analysis Of Influencing Factors
195.	The Clinical Characteristics And Prognosis Of Chronic Myeloid Leukemia
196.	Study On The Relationship Between The Expression Level Of MiR-221 In Peripheral Blood And The Acquired Resistance Of The First Generation Of EGFR-TKIs In Lung Cancer
197.	Survivalanalysis For Gastrointestinal Stromal Tumor Patients With Liver Metastases
198.	Resensitizing To Tyrosine Kinase Inhibitor By Inhibiting PFKFB3 In TKI Resistant Chronic Myelogenous Leukemia Cells
199.	Effect Of TKI On Chronic Myeloid Leukemia Of Different Course And Influencing Factors Of Molecular Response
200.	Treatment Status Of Chronic Myeloid Leukemia In The Era Of Tyrosine Kinase Inhibitors
<<First <Prev Next> Last>> Jump to